Signalife Adds Three Prominent Board Members
Monday July 16, 9:15 am ET
LOS ANGELES, July 16 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN - News) announced early today that it has added three very prominent physicians -- two of which are former senior officials in governmental health departments, and all of which are successful businessmen -- to its Board of Directors. With these additions, the Company intends to form a Technology Review and Distribution Committee of its Board, to guide the current initiatives involving the Company.
Added to the Board are Steven Joseph Phillips, M.D., Robert E. Windom, M.D. and Jay A. Johnson, M.D. All three physicians have extensive business, regulatory and practical experience in cardiology and health care. The physicians also have extensive experience in one or more different but complementary medical areas that will use the Signalife Fidelity 100 heart monitor for slightly different purposes and benefits -- cardiology, internal medicine, and cardiac surgery -- which will allow the company to use their expertise to develop strategies to more effectively market the Fidelity 100 in each such area. In addition to acting as directors and assisting the company in developing its product placement marketing strategies, the physicians will also introduce the company and the Fidelity 100 to numerous "marquee" hospitals and physician groups.
Steven Joseph Phillips, M.D.
Dr. Phillips, from Bethesda, Maryland, is currently engaged by the National Institutes of Health. He served as a cardiac surgeon at Iowa Heart Center from 1974 to his official retirement date of 2005 -- a span of some 30 years. Dr. Phillips' achievements and experience are literally too broad in scope to list in a press release. They will be outlined in more detail on the Company's website. Among these are his positions at the prestigious Cardiac Hospitals of America, a for profit organization with which Dr. Phillips is still involved. Prior to that, Dr. Phillips was Deputy to the Director of Research and Education, National Library of Medicine, National Institutes of Health. Some of his other more recent positions include the National Science Advisor for the Iowa Department of Health as well as serving on the Board of Directors in Iowa for the American College of Cardiology. Dr. Phillips received his Bachelor of Arts from Hobart College, Geneva, NY and his Doctor of Medicine in 1966 from Tufts University School of Medicine, Boston, MA. Afterwards, Dr. Phillips served with the United States Army in the 101st Airborne Division, 27th Surgical Hospital. Over the years, Dr. Phillips has published hundreds of scientific articles in medical journals.
Commenting on his appointment to Signalife's Board, and after a thorough technology review, Dr. Phillips said: "The spectrum of technology presented by Signalife exceeds by magnitudes all existing systems. The Fidelity 100 is the 'grail' of ambulatory EKG monitoring that I have been seeking for nearly 40 years. In my opinion, the Signalife Fidelity 100 and associated technologies will create a paradigm shift in the way we monitor and detect cardiac life threatening events. The Fidelity 100 will save lives and is appropriate not only for cardiac patients, but for the general public as well."
Robert E. Windom, M.D.
Much like Dr. Phillips, Robert E. Windom, M.D. possesses an array of experience and industry-wide connections that are critical at this juncture of Signalife's development. A graduate of Duke University -- both undergraduate as well as his medical degree -- Dr. Windom has had an extremely distinguished career in internal medicine and cardiology through his practice in Sarasota, Florida. Among other appointments, Dr. Windom is currently the President of the World Immuno Society for Health, a member of the Board of the Florida Medical Directors Association, a Special Advisor to the Secretary, Florida Department of Health, and numerous other public and private Boards spanning a spectrum of health care to banking. Dr. Windom has also received numerous awards throughout his distinguished career, including Distinguished Internist of the Year from the American Society of Internal Medicine. Over his career, Dr. Windom has engaged in significant international activities as an Assistant Secretary of Health, and is the author of over 30 publications.
In evaluating the prospects for the technology, Dr. Windom said he was "amazed" that a cardiac device "can receive such a precise recording under many and varied conditions." Dr. Windom "foresees" that the Fidelity 100 "will revolutionize the industry because there is nothing on the horizon that approaches its accuracy." In the words of Dr. Windom, the result is "better patient care."
Jay A. Johnson, M.D.
Dr. Johnson is a Board Certified Internist and Cardiologist. Currently, Dr. Johnson is an attending physician at Stanford University Hospital. He holds a Bachelors degree as well as both a Masters Degree and a Medical Degree, the latter from George Washington University in 1990. He is the recipient of numerous awards, including from the American College of Cardiology.
Commenting on his appointment to the Company's Board, Dr. Johnson -- who has been working with and evaluating the technology for nearly one year -- called the technology "remarkable." Continuing, he indicated that "the Signalife, Fidelity 100 is the most advanced technology in ECG monitoring available today. The ability of the Fidelity 100 to capture clean ECG tracings in an active, ambulatory setting will greatly enhance our ability to detect cardiac disease early and will lead to life-saving intervention."
